The peroxisome proliferator-activated receptor-α agonist, BAY PP1, attenuates renal fibrosis in rats
about
Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathwaysPeroxisome proliferator-activated receptor δ agonist, HPP593, prevents renal necrosis under chronic ischemia.Mesenchymal stem cells from rats with chronic kidney disease exhibit premature senescence and loss of regenerative potentialCompromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.PPARα Activation Protects against Anti-Thy1 Nephritis by Suppressing Glomerular NF-κB Signaling.Proximal tubule PPARα attenuates renal fibrosis and inflammation caused by unilateral ureteral obstruction.Tempol attenuates renal fibrosis in mice with unilateral ureteral obstruction: the role of PI3K-Akt-FoxO3a signaling.The extracellular matrix in the kidney: a source of novel non-invasive biomarkers of kidney fibrosis?Renal allograft fibrosis: biology and therapeutic targets.Notch-3 receptor activation drives inflammation and fibrosis following tubulointerstitial kidney injury.A mouse model of alcoholic liver fibrosis-associated acute kidney injury identifies key molecular pathways.Novel Anti-fibrotic Therapies.Diffusion-weighted MRI does not reflect kidney fibrosis in a rat model of fibrosis.Seven weeks of Western diet in apolipoprotein-E-deficient mice induce metabolic syndrome and non-alcoholic steatohepatitis with liver fibrosisComprehensive assessment of nephrotoxicity of intravenously administered sodium-oleate-coated ultra-small superparamagnetic iron oxide (USPIO) and titanium dioxide (TiO2) nanoparticles in rats.Contrast-enhanced CT imaging in patients with chronic kidney disease.The renal (myo-)fibroblast: a heterogeneous group of cells.
P2860
Q30405346-C330ACAD-F71E-4D2F-AA23-FE4DD7744166Q34731608-2AFEA04B-9703-413D-8F9C-A0DA4E37B6E1Q35130910-325B31CC-58C8-4221-A53E-B937235CEFF7Q35549268-CD373319-8473-40E3-9A23-6AA7487FEB88Q35997191-34EAD4AE-3FBA-4CDB-A5F6-028DC01180FDQ37142522-F3E12291-0942-4355-B5CC-67F56ABA222DQ37583050-07B1CF11-7C0A-4229-9024-C76E3D450342Q37702664-D9926E91-8B55-4E45-A502-6E5DE69AE769Q38359455-14E5C0D3-AC92-48E5-BD70-3CCAD5DD8D48Q39313049-7292618A-3D1B-4176-86D9-EA3749692D7AQ39376604-39F3E376-EEE4-4062-B44D-6EC28E79BA40Q39377055-3D318E25-524D-42AE-ADD5-F31AAD3C1C00Q41512822-0E87ABF8-9B7D-4AED-82BE-885F8A06BF75Q41870298-CACC9D42-33DF-4257-9FA9-931714C26B8FQ43465717-E6ABCAAB-B3B4-492C-8BD8-17181F067CCBQ48374957-20AB06ED-3F77-497F-9A29-4533D881A832Q48634875-C42AB160-6939-422D-B274-A87BDF13C0E4
P2860
The peroxisome proliferator-activated receptor-α agonist, BAY PP1, attenuates renal fibrosis in rats
description
im Dezember 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 03 August 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2011
@uk
name
The peroxisome proliferator-ac ...... enuates renal fibrosis in rats
@en
The peroxisome proliferator-ac ...... enuates renal fibrosis in rats
@nl
type
label
The peroxisome proliferator-ac ...... enuates renal fibrosis in rats
@en
The peroxisome proliferator-ac ...... enuates renal fibrosis in rats
@nl
prefLabel
The peroxisome proliferator-ac ...... enuates renal fibrosis in rats
@en
The peroxisome proliferator-ac ...... enuates renal fibrosis in rats
@nl
P2093
P50
P356
P1433
P1476
The peroxisome proliferator-ac ...... enuates renal fibrosis in rats
@en
P2093
August Heidland
Barbara Albrecht-Küpper
Ciro Esposito
Ina V Martin
Kristína Klenovicsová
Luigi Villa
Stefan Schäfer
Tammo Ostendorf
P2888
P304
P356
10.1038/KI.2011.254
P407
P577
2011-08-03T00:00:00Z